RE:RE:RE:RE:RE:RE:Next news and Share acquisition extensionJust read the news release on Dec 4th again and things are very clear;
With the debt settlement filed Jenex has applied to graduate to the TSXV. Jenex would like to report that testing on the Zika Virus with our patent pending TherOZap™ technology is complete and the Company will report results and further data when available which is expected prior to year-end.
I am holing on to this thing.